BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lefebvre M, Vignier N, Pitard B, Botelho-Nevers E, Wyplosz B, Cohen R, Epaulard O; SPILF Vaccination Prevention group. COVID-19 vaccines: Frequently asked questions and updated answers. Infect Dis Now 2021;51:319-33. [PMID: 33681861 DOI: 10.1016/j.idnow.2021.02.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Saban M, Myers V, Ben Shetrit S, Wilf-Miron R. Issues surrounding incentives and penalties for COVID-19 vaccination: The Israeli experience. Prev Med 2021;153:106763. [PMID: 34352308 DOI: 10.1016/j.ypmed.2021.106763] [Reference Citation Analysis]
2 Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol 2021;99:108021. [PMID: 34352567 DOI: 10.1016/j.intimp.2021.108021] [Reference Citation Analysis]
3 Boschiero MN, Palamim CVC, Ortega MM, Mauch RM, Marson FAL. One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview. Ann Glob Health 2021;87:44. [PMID: 34046307 DOI: 10.5334/aogh.3182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kiriacos CJ, Khedr MR, Tadros M, Youness RA. Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha. Front Oncol 2022;12:837408. [PMID: 35664773 DOI: 10.3389/fonc.2022.837408] [Reference Citation Analysis]